All Episodes
OncoPharm — 446 episodes · page 1 of 5
Blinatumomab & Ponatinib for ALL
HER2 Climb 05
Lirafugratinib + LITESPARK011
PI3K Pathway Hyperglycemia
Neutropenic Diets & Lung Cancer Updates
How to Read a Press Release and Drug Shortage Help
Paradigm and Daraxonrasib in NSCLC
Daraxonrasib, Zanidatamab, and CNS Lymphoma Updates
Iberdomide
Kidney Cancer in a Nutshell
Small Cell Lung Cancer and CINV Updates
Zidesamtinib & PPIs in Pacific
Gedatolisib et al
Endurance Part 2
A Decade of CAR-T, Ocra-T, & POLARGO
Breast Cancer Updates and T-Cell Stemness
Updates on capivasertib, belzutifan, talquetamab, & durvalumab
ASCO '26
Pivekimab sunirine
BCL2 & HER2 Targeting Agent Updates
IMHOTEP, PJP, and more
Vepdegestrant
Targets Trop 2
Promising Pancreatic Cancer Data
ICI-Induced T1DM
Relacorilant
HOPA 2026 Recap
Nivo-AVD Approval
Tazemetostat Withdrawl and RECITE
FDA Approval Updates Galore
BR.31 & ASCO GU '26
Rezatapopt and Colchicine for Trametnib/Dabrafenib Pyrexia
Perioperative Enortumab vedotin + Pembrolizumab
Axi-Cel and 5-FU Label Changes
Core Communication Skills in Chemotherapy Education
PATINA
Sacituzumab govitecan + pembrolizumab and ASCO GI '26
Oncology Drug Use Evolution
2025 New Drug Review
Bladder Cancer Updates & SC Amivantamab
ASH 2025
DPYD Deficiency Testing
Cornucopia of Autumn Updates
PGYNone: Dandelion Effect
PGY1 Pathway: Road Trip!
PGY2 Pathway: A Planned City
Tale from the Crypt: Belantamab Mafodotin
ESMO 2025
IL-2
Maintenance Therapy in Small Cell Lung Cancer
PARAMOUNT - Maintenance Pemetrexed
SC Pembro, Biotin, 5-yr POLARIX data
ALASCCA
EGFRm NSCLC Updates
Time to Cilta-Cel-ebrate?
RNA Vaccine Potential as a Cancer Treatment
Venetoclax Dosing & APOLLO
Zongertinib
Dordaviprone & RCT to prevent ADRs
ProMACE-CytaBOM
Testicular Cancer in a Nutshell
Supportive Care Updates
Linvoseltamab & sunvozertinib
Antiandrogen Withdrawal
June 2025 Updates
ASCO 2025
CLEOPATRA
Talking about cancer misinformation
Four New Drugs
Mg to Prevent Cisplatin Kidney Injury
TI-CH, Updates on dostarlimab, ventoclax, & zongertinib
BRCA Reversion Mutations
HOPA 25 Recap
Expanded Approvals for Durvalumab, Lu 177 vt; Portland Preview
Topotecan
API-CAT & IMPROVE
Keynote 811 Update
Polar: Cryotherapy or Compression to Prevent Taxane-induced neuropathy
About Herb Drug Interactions
Rethinking Premeds
AMPLIFY
OncoPharm M & M: Fatal TLS & Fatal T-cell lymphoma post-CAR-T
[Re-release] Rituximab
Acalabrutinb + BR and sotorasib + panitumumab
Datoptamab deruxtecan
Dex Dosing in MM, Tec-Tal, & postMONARCH
Breakwater, Ensartinib, & SC Nivo
The Accelerated Approval Pathway
2024 New Drug Review
A Feast Of Updates
Zenocutuzumab
Revumenib
Anthracycline Use In Breast Cancer
SWISH
Zolbetuximab
S1826 & INTERLACE
Inavolisib
Autumnal (2024) AML Updates
MSI-High Rectal Cancer Treatment
NATALEE + a slew of FDA updates